Non-promotional in-service PADCEV ® (Enfortumab Vedotin)

When:  Jan 13, 2026 from 17:30 to 19:00 (CT)
Associated with  Southeast Minnesota

Non-promotional in-service PADCEV ® (Enfortumab Vedotin) Perioperative enfortumab vedotin (EV) plus pembrolizumab (pembro) in patients with muscle-invasive bladder cancer (MIBC) who are cisplatin ineligible: The phase 3 EV-303 study.

Presenter:
Jason Cohen, PhD
Medical Science Liaison – GU Oncology
Medical Affairs, Americas | Astellas Pharma, Inc

Where:
Ruth’s Chris Steak House
20 Second Avenue Southwest
Rochester, MN 55902

When:
Tuesday, January 13
5:30 pm – 7:00 pm

Please RSVP to Mark Hubly
mark.hubly@astellas.com
(507) 261-4399

Location

Ruth's Chris
20 Second Avenue Southwest
Rochester, MN 55902